Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
534.00
-19.15 (-3.46%)
Nov 3, 2026, 2:03 PM EST - Market open

Vertex Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Equivalents
6,3036,1445,4935,0854,9404,9724,6754,5705,2394,5809,15810,36911,11010,1519,29010,5049,1728,7027,6006,795
Short-Term Investments
-1,7091,7541,5231,3471,4111,5271,5461,2851,2151,013849.28181,0851,124274.5599.2551.2638729.9
Cash & Short-Term Investments
6,3037,8527,2476,6086,2876,3836,2016,1166,5255,79610,17111,21811,92811,23610,41410,7799,7719,2538,2387,525
Cash Growth (YoY)
0.26%23.02%16.86%8.05%-3.64%10.13%-39.03%-45.48%-45.30%-48.42%-2.33%4.08%22.08%21.43%26.41%43.24%40.37%37.95%18.98%13.00%
Accounts Receivable
2,3112,1341,9962,0531,9461,8941,8051,6091,7511,6561,7931,5631,5391,5561,5481,4421,3851,3331,2931,137
Receivables
2,3112,1341,9962,0531,9461,8941,8051,6091,7511,6561,7931,5631,5391,5561,5481,4421,3851,3331,2931,137
Inventory
2,2451,7651,7671,6871,6271,4991,3601,2051,080914.6813.1738.8688.7603.5535.1460.6388.2367.7338.9353.1
Prepaid Expenses
826.7720.5672.7736.2694.5639.9581.6459.2438.7528.5473.4537.6496467.8443.5431.6529.8428.7430.4442.1
Restricted Cash
-10.612-8.29.810.7-8.910.911.4-6.42.35.7-5.51.93.95.1
Other Current Assets
-60.836.1117.16.72.650.5206.51.63626.386.137.86.819.5121.9191.6118.957.298.6
Total Current Assets
11,68612,54411,73011,20110,57010,42810,0099,5969,8048,94213,28914,14414,69613,87312,96613,23512,27111,50410,3619,561
Property, Plant & Equipment
3,3293,3283,2943,0833,0172,6492,6342,5852,5141,7711,4861,4531,4351,4471,4481,4561,4611,4181,4361,424
Long-Term Investments
3,5185,8695,8315,7945,8045,7125,2215,1734,7784,4784,4562,4981,7991,4561,180112.298.695.885.8-
Goodwill
-1,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0751,0021,0021,002
Other Intangible Assets
10,941412.8418.5424.2429.8435.5441.2825.9831.6837.5834.9839.9603.6603.6603.6603.6603.6387400400
Long-Term Deferred Tax Assets
1,9533,0112,9482,8982,9372,7122,5442,3312,3092,1861,9631,8121,7291,5381,3601,2471,1631,144945.5934.5
Long-Term Deferred Charges
---66.6---62.6---58.9---40.2----
Other Long-Term Assets
1,3091,1711,1751,0891,0171,012942.6871.9916.1830.3801.4836.4376.6344.1328.9369.433.931.524.9110.8
Total Assets
32,73627,42326,48425,64324,86224,03722,88122,53322,24020,13223,91722,73021,72620,34918,97418,15116,70615,58214,25613,433

Liabilities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Accounts Payable
3,708429.5489.3461.7420.3442.3445413395.8327.9351.4364.9375.9363323.2303.9126.9198173.6195
Accrued Expenses
-3,1792,9842,7823,6143,2712,9522,5843,2202,9402,7962,5562,9072,5982,3262,0032,2642,1201,7211,467
Short-Term Debt
999.6-------------------
Current Portion of Leases
---82.8---92.371.2--83.7---89.4---80.2
Current Income Taxes Payable
---103.1---161.1---99.5---123.3---211.3
Current Unearned Revenue
-157218.7171.8182146.9228.4206.8220128.3275.8170.3157.1179.1236.4159.6119.5134.8186.1171.7
Other Current Liabilities
293172.4188.4259.7259.5278.5158107.466.4151372.8273.2159.1211.9140.662.598.5103.910016.5
Total Current Liabilities
5,0003,9383,8813,8614,4754,1383,7833,5653,9733,5473,7963,5473,5993,3523,0262,7422,6092,5562,1802,142
Long-Term Debt
3,497-------------------
Long-Term Leases
1,9821,9781,9871,9531,8351,5271,6491,6571,703933.4721.3724.7744.7767.6789.2810.3824.6847.3872.5887.2
Other Long-Term Liabilities
1,3501,2601,2551,1631,2331,196951.9901.8933.3876.8853.6877.7869.3759.3726.5685.8242.9245.2296.4303.3
Total Liabilities
11,8297,1757,1236,9777,5446,8616,3846,1246,6095,3575,3715,1505,2134,8794,5424,2383,6773,6493,3493,333

Shareholders' Equity

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Common Stock
20,9072.52.52.52.52.62.62.62.62.62.62.62.62.62.62.62.62.62.62.5
Additional Paid-In Capital
-4,5064,7435,1195,0125,9886,1736,6726,9067,1017,2857,4507,3407,3697,2207,3877,2267,1006,9306,881
Retained Earnings
-15,69114,59113,56012,36911,28610,2539,6078,6947,64811,24210,1429,1748,1387,2236,5235,7044,7733,9633,201
Comprehensive Income & Other
-48.524.8-15.9-64.5-101.168.1127.828.822.517.3-14.3-3-39.8-13.10.897.657.511.315.9
Total Common Equity
20,90720,24819,36218,66617,31917,17516,49616,41015,63114,77518,54717,58016,51315,47014,43213,91313,03011,93410,90710,100
Shareholders' Equity
20,90720,24819,36218,66617,31917,17516,49616,41015,63114,77518,54717,58016,51315,47014,43213,91313,03011,93410,90710,100
Total Liabilities & Equity
32,73627,42326,48425,64324,86224,03722,88122,53322,24020,13223,91722,73021,72620,34918,97418,15116,70615,58214,25613,433

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Total Debt
6,4781,9781,9872,0361,8351,5271,6491,7501,774933.4721.3808.4744.7767.6789.2899.7824.6847.3872.5967.4
Net Cash (Debt)
3,34311,66411,01010,28410,17510,5019,7099,4749,4549,25513,83112,90812,88411,82610,7069,9918,9468,4067,3666,558
Net Cash Growth (YoY)
-67.15%11.07%13.41%8.55%7.63%13.46%-29.81%-26.60%-26.62%-21.74%29.19%29.19%44.01%40.68%45.36%52.36%47.04%44.58%22.25%14.71%
Net Cash Per Share
13.1045.7042.9640.1639.5040.5637.4136.3736.2235.8652.9749.4749.4445.4141.1338.3834.4732.4928.5625.52
Filing Date Shares Outstanding
253.5253.46253.81254.03253.72256.39256.8256.79257.53258.1258.05258.31257.68258.09257.55257.09256.69256.46255.76254.58
Total Common Shares Outstanding
253.5253.35254.16253.99253.95256.29256.97256.94257.74258.02258.3257.7257.83257.79257.51257.01256.65256.03255.57254.48
Working Capital
6,6868,6067,8507,3406,0946,2906,2266,0325,8315,3949,49310,59711,09610,5219,94010,4939,6628,9478,1817,419
Book Value Per Share
82.4779.9276.1873.4968.2067.0164.2063.8760.6557.2671.8068.2264.0560.0156.0554.1350.7746.6142.6839.69
Tangible Book Value
9,96618,74717,85517,15415,80115,65214,96714,49613,71112,84916,62415,65314,82113,77912,74112,22111,35110,5449,5058,698
Tangible Book Value Per Share
39.3174.0070.2567.5462.2261.0758.2556.4253.2049.8064.3660.7457.4853.4549.4847.5544.2341.1837.1934.18
Land
---33.1---33.1---33.1---33.1---33.1
Buildings
---483.8---461.2---928.6---903.1---892.5
Machinery
---1,198---1,061---911.9---788.6---701
Leasehold Improvements
---1,009---737.6---474.6---410.9---363.5
SEC Filings: 10-K · 10-Q